Prevalence and Prognostic Significance of Heart Failure With Preserved Ejection Fraction in Systemic Sclerosis

References

• Denton CP , KhannaD. Systemic sclerosis. Lancet, 390(10103), 1685–1699 (2017).
   PubMed Web of Science ®Google Scholar
• Sitia S , AtzeniF, Sarzi-PuttiniPet al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun. Rev., 8(4), 281–286 (2009).
   PubMed Web of Science ®Google Scholar
• Rubio-Rivas M , RoyoC, SimeónCP, CorbellaX, FonollosaV. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin. Arthritis Rheum., 44(2), 208–219 (2014).
   PubMed Web of Science ®Google Scholar
• Tyndall AJ , BannertB, VonkMet al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis., 69(10), 1809–1815 (2010).
   PubMed Web of Science ®Google Scholar
• Bissell L-A , AndersonM, BurgessMet al. Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology (Oxford), 56(6), 912–921 (2017).
   PubMed Web of Science ®Google Scholar
• Kahan A , AllanoreY. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford), 45(Suppl. 4), iv14–iv17 (2006).
   PubMedGoogle Scholar
• Bissell L-A , MdYusof MY, BuchMH. Primary myocardial disease in scleroderma - a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group. Rheumatology (Oxford), 56(6), 882–895 (2017).
   PubMed Web of Science ®Google Scholar
• Tennøe AH , MurbræchK, AndreassenJCet al. Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis. J. Am. Coll. Cardiol., 72(15), 1804–1813 (2018).
   PubMed Web of Science ®Google Scholar
• van den Hoogen F , KhannaD, FransenJet al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum., 65(11), 2737–2747 (2013).
   PubMedGoogle Scholar
• Avouac J , FransenJ, WalkerUAet al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann. Rheum. Dis., 70(3), 476–481 (2011).
   PubMed Web of Science ®Google Scholar
• Lang RM , BadanoLP, Mor-AviVet al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr., 28(1), 1–39.e14 (2015).
   PubMed Web of Science ®Google Scholar
• Ponikowski P , VoorsAA, AnkerSDet al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail., 18(8), 891–975 (2016).
   PubMed Web of Science ®Google Scholar
• Hoffmann-Vold A-M , MaherTM, PhilpotEEet al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatol., 2(2), e71–e83 (2020).
   PubMedGoogle Scholar
• Gerber Y , WestonSA, RedfieldMMet al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern. Med., 175(6), 996–1004 (2015).
   PubMed Web of Science ®Google Scholar
• Owan TE , HodgeDO, HergesRM, JacobsenSJ, RogerVL, RedfieldMM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med., 355(3), 251–259 (2006).
   PubMed Web of Science ®Google Scholar
• Andersson C , VasanRS. Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin., 10(3), 377–388 (2014).
   PubMed Web of Science ®Google Scholar
• Ceia F , FonsecaC, MotaTet al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur. J. Heart Fail., 4(4), 531–539 (2002).
   PubMed Web of Science ®Google Scholar
• Desai CS , LeeDC, ShahSJ. Systemic sclerosis and the heart: current diagnosis and management. Curr. Opin. Rheumatol., 23(6), 545–554 (2011).
   PubMed Web of Science ®Google Scholar
• Parks JL , TaylorMH, ParksLP, SilverRM. Systemic sclerosis and the heart. Rheum. Dis. Clin. North Am., 40(1), 87–102 (2014).
   PubMed Web of Science ®Google Scholar
• Bellando-Randone S , LepriG, HuscherD. Predictors to develop definite systemic sclerosis (SSc): results from an International Multicentre Study on very early diagnosis of systemic sclerosis (VEDOSS). ACR meeting abstracts. https://acrabstracts.org/abstract/predictors-to-develop-definite-systemic-sclerosis-ssc-results-from-an-international-multicentre-study-on-very-early-diagnosis-of-systemic-sclerosis-vedoss/
   Google Scholar
• Hinchcliff M , DesaiCS, VargaJ, ShahSJ. Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis. Clin. Exp. Rheumatol., 30(71 Suppl. 2), S30–S37 (2012).
   PubMed Web of Science ®Google Scholar
• Vasan RS , LarsonMG, BenjaminEJ, EvansJC, ReissCK, LevyD. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol., 33(7), 1948–1955 (1999).
   PubMed Web of Science ®Google Scholar
• Zakeri R , ChamberlainAM, RogerVL, RedfieldMM. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation, 128(10), 1085–1093 (2013).
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA , VlachoyiannopoulosPG, HaidichA-Bet al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am. J. Med., 118(1), 2–10 (2005).
   PubMed Web of Science ®Google Scholar
• Lefèvre G , DauchetL, HachullaEet al. Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum., 65(9), 2412–2423 (2013).
   PubMed Web of Science ®Google Scholar
• Fisher MR , MathaiSC, ChampionHCet al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum., 54(9), 3043–3050 (2006).
   PubMed Web of Science ®Google Scholar
• Bourji KI , KelemenBW, MathaiSCet al. Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulm. Circ., 7(2), 409–420 (2017).
   PubMed Web of Science ®Google Scholar